The Department of Pharmacology and Cancer Biology offers graduate degrees in both Pharmacology and Molecular Cancer Biology. The two graduate programs complement the diverse research interests of the department which broadly include cancer biology, cell biology, neurobiology, toxicology and pharmacology. The graduate programs are intended to reflect the interdisciplinary nature of the department and to promote collaboration. The curricula are designed to provide a strong foundation in pharmacology or cancer biology while maintaining flexibility to pursue elective courses tailored for the student’s future research interests.
Guaranteed Funding
Graduate positions in the program are fully funded providing for payment of tuition, fees, and an annual stipend for the first year. After year one, students are supported by the faculty member with whom they are doing their thesis research. The average time to completion of a Ph.D. is 5.5 years
Why Duke PCB?
The Department currently includes 24 primary faculty and 33 secondary faculty with primary appointments in departments such as molecular genetic and microbiology, cell biology, cardiology, medicine, and neurobiology.
The collaborative and collegial atmosphere between faculty and students provides a wide diversity of research opportunities
Ready to apply?
